US Patent 11890293 Synthetic composition for treating metabolic disorders
Patent 11890293 was granted and assigned to Glycom A/S on February, 2024 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
January 5, 2021
0
Date of Patent
February 6, 2024
0
Patent Applicant
Patent Application Number
17141772
0
Patent Citations
Patent Inventor Names
Emma Elison
0
Bruce McConnell
0
Louise Kristine Vigsnæs
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11890293 Synthetic composition for treating metabolic disorders
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.